Monoferric (Ferric Derisomaltose)

Ferric derisomaltose, the active ingredient in Monoferric, is an iron preparation presented as an intravenous solution for intravenous use. It treats iron deficiency anemia in adults, including anemia associated with chronic kidney disease, postoperative anemia, and pregnancy‑related iron deficiency when indicated.

GNH USA supplies Monoferric as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Monoferric is used to manage conditions related to iron deficiency anemia.

Iron deficiency anemia in adults: restores hemoglobin levels and replenishes iron stores. Chronic kidney disease‑associated anemia: provides rapid iron repletion to support erythropoiesis. Postoperative anemia: corrects peri‑operative iron loss and aids recovery. Pregnancy‑related iron deficiency (when indicated): supplies elemental iron to meet increased maternal demands.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Headache: transient pain often resolving without intervention. - Infusion site reactions: erythema, pain, or swelling at the injection site. - Dizziness: temporary light‑headedness during or after infusion. - Flushing: brief warmth or redness of the skin. - Muscle cramps: occasional tightness in limbs.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hypotension: sudden drop in blood pressure during infusion. - Acute respiratory distress: difficulty breathing or wheezing. - Severe hypertension: abrupt elevation of blood pressure. - Cardiac arrest: rare but life‑threatening cardiac event. - Serum ferritin elevation: excessive iron accumulation detectable in labs.

Before initiating therapy, evaluate iron status and underlying causes of anemia.

Assess iron overload risk: avoid use in patients with known iron excess. Monitor hemoglobin and ferritin: check levels periodically during treatment. Use cautiously in patients with a history of hypersensitivity to IV iron. Infuse at recommended rate: rapid administration may increase adverse reactions. Administer under medical supervision: ensure emergency measures are available. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Monoferric may interact with other agents that affect iron metabolism or cardiovascular stability.

Major Interactions (Avoid): - Other intravenous iron products: risk of cumulative iron overload. - Known hypersensitivity to IV iron complexes: may trigger severe allergic response. - High‑dose vitamin C administered concurrently: can increase free iron and oxidative stress.

Moderate Interactions (Monitor Closely): - Oral iron supplements: may reduce absorption efficiency if given simultaneously. - Antihypertensive medications: monitor blood pressure due to potential hypotensive effect. - Antacids or proton‑pump inhibitors: may alter infusion tolerance or cause gastrointestinal discomfort.